Presentation TCT 2024 The ALIGN-AR Trial: Two-Year Outcomes of Transcatheter Aortic Valve Replacement With JenaValve TrilogyTM in High Surgical Risk Patients With Moderate-to-Severe or Severe Native Aortic Regurgitation Presenter: Torsten Vahl October 29, 2024
News Conference News TCT 2024 DCB Outdo Noncompliant Balloons in Simple Bifurcation Side Branches: DCB-BIF Caitlin E. Cox October 28, 2024
News Conference News TCT 2024 More Registry Data Show Post-TAVI Benefits With Sentinel but No Stroke Impact Yael L. Maxwell October 28, 2024
News Conference News TCT 2024 TAVR UNLOAD: No Rush to Do TAVI in HFrEF Patients With Moderate AS Todd Neale October 28, 2024
News Conference News TCT 2024 EVOLVED: Early AVR Fails to Help Asymptomatic AS Patients With Fibrosis Michael O'Riordan October 28, 2024
Presentation TCT 2024 The EARLY TAVR Trial Editorial Commentary Presenter: Bernard Prendergast October 28, 2024
Presentation TCT 2024 Early Intervention in Patients With Asymptomatic Severe Aortic Stenosis and Left Ventricular Myocardial Fibrosis Presenter: Mark Dweck October 28, 2024
Presentation TCT 2024 Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: The TAVR UNLOAD Trial Presenter: Nicolas Van Mieghem October 28, 2024
Presentation TCT 2024 TCT 616: Wire-Assisted Percutanoeus Mitral Commisuratomy Is Significantly Faster Than the Tradidtional Inoue Balloon Technique: A Randomized Clinical Trial Presenter: Chala Oljira October 28, 2024
Presentation TCT 2024 Transcatheter Aortic Valve Replacement for Asymptomatic Severe Aortic Stenosis: Results of the EARLY TAVR Trial Presenter: Philippe Genereux October 28, 2024
Presentation TCT 2024 A Sensible Approach to CEP for TAVR: From Clinical Trials to Clinical Practices Presenter: Aakriti Gupta October 28, 2024
News Conference News TCT 2024 EARLY TAVR Breaks New Ground for Preemptive Treatment of Asymptomatic AS L.A. McKeown October 28, 2024
Presentation TCT 2024 TCT 974: Characteristics and Outcomes of Patients Screened out of Tricuspid Transcatheter Edge-to-Edge Repair or Transcatheter Tricuspid Valve Replacement Clinical Trials Presenter: Tai Pham October 28, 2024
News Conference News TCT 2024 New DanGer Shock Data: Hemodynamics, Renal Dysfunction, and Bleeding Caitlin E. Cox October 28, 2024
Presentation TCT 2024 1-Year and Landmark 6-12 Month Clinical Outcomes Among Patients in Complex Lesion Subsets Treated With DynamX Bioadaptor Compared to a Contemporary Drug Eluting Stent From the INFINITY-SWEDEHEART Presenter: David Erlinge October 28, 2024
Presentation TCT 2024 TCT 1010: Enhanced Clinical Benefit of Preventive PCI of Vulnerable Coronary Plaques in Patients With Concomitant Non-Target Vessel PCI: A Prespecified Subgroup Analysis of the PREVENT Trial Presenter: Soo Yeon An October 28, 2024
Presentation TCT 2024 TCT 1006: Impact of Angiographic Diameter Stenosis on the Clinical Benefit of Preventive PCI of Vulnerable Plaque: A Post-hoc Analysis of the PREVENT Trial Presenter: Do-Yoon Kang October 28, 2024
Presentation TCT 2024 TCT 492: One-Year Clinical Outcomes After PCI With AGENT Paclitaxel-Coated Balloon Among Underrepresented Racial and Ethnic Subgroups With In-Stent Restenosis: Analysis of the AGENT IDE Trial Presenter: NULL October 28, 2024
Presentation TCT 2024 Transcatheter Valve Selection for Redo TAVR and Overview of Clinical Trials Presenter: Radoslaw Parma October 28, 2024
Presentation TCT 2024 Clinical Trials in the Post ATTRACT Era: What is the New State of the Art Data and Upcoming Trials Guiding DVT Intervention? Presenter: Suresh Vedantham October 28, 2024